We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Report Discusses POC Testing and Changing Paradigms

By LabMedica International staff writers
Posted on 20 Jun 2017
The American Academy of Microbiology has released a new report on the role of the role of point-of-care (POC) and near-patient testing in changing diagnostic paradigms in microbiology.

Technology for diagnosing infectious diseases in patients is rapidly advancing, and new diagnostic tests have the potential to meaningfully improve patient care. More...
Recommendations for the Academy’s report (Changing Diagnostic Paradigms for Microbiology, published May 2017) were based on discussions of a panel of experts. The Academy convened a colloquium October 17-18, 2016, (Washington, DC; USA) to explore the development and implementation of near-patient and POC testing and to provide recommendations for using these tests to improve patient care across clinical settings.

“Rapid diagnostic tests have the potential to deliver timely results, enable treatment decisions by detecting the presence of biomarkers, distinguish between viral and bacterial infections, identify causative organisms, and provide information on drug resistance,” said Melissa Miller, PhD, steering committee chair of the colloquium. The report focuses on the unmet needs for research and development of new diagnostic tests, for ongoing regulatory review of POC tests, and for laboratorian expertise, even in near-patient settings. The participants also discussed the importance of proper interpretation of test results, and linking test results to electronic medical records. They emphasized the need for microbiology experts to guide the development and utilization of tests and ensure proper reporting of results.

“The expertise of clinical microbiologists is essential to maximizing the value and minimizing the risk of POC infectious disease diagnostics, provided that clinical microbiologists adapt their practice to this setting,” said Sheldon Campbell, MD, PhD, Yale School of Medicine, a participant in the colloquium.

The report summarized proper utilization of tests (such as ordering appropriate tests and correctly interpreting results), the need for proper training and education on test usage, and contamination concerns. It also discussed regulation of the tests (reporting issues to FDA, CMS requirements), and the importance of documenting results and reporting to health departments when necessary. For the future, participants agreed that POC tests should be linked to web-based quality and performance matrices that would revolutionize POC testing quality and reach.

A commentary with additional information on advances in diagnostics, Advances Afoot in Microbiology by Mayo Clinic’s Patel R and Karon BS, was published May 24, 2017, in the Journal of Clinical Microbiology.


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Portable Electronic Pipette
Mini 96
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The nanotechnology-based liquid biopsy test could identify cancer at its early stages (Photo courtesy of 123RF)

2-Hour Cancer Blood Test to Transform Tumor Detection

Glioblastoma and other aggressive cancers remain difficult to control largely because tumors can recur after treatment. Current diagnostic methods, such as invasive biopsies or expensive liquid biopsies,... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.